Chronic liver diseases and parenterally transmitted hepatitis viruses

被引:0
作者
Ivanova, L. [1 ]
Russev, V. [1 ]
机构
[1] Med Univ Varna, Univ Hosp St Marina, Lab Clin Microbiol & Virol, Varna 9000, Bulgaria
关键词
hepatitis B virus; hepatitis C virus; hepatitis D virus; chronic liver diseases; ELISA; C-VIRUS; B-VIRUS; INFECTION; COINFECTION; REPLICATION; PROGRESS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) are the leading cause of chronic liver. diseases. The aims of the present study are to determine the etiological relationship of HBV and HCV in patients with chronic liver disease in North-Eastern Bulgaria and prevalence of dual and triple infections. A total of 434 patients were investigated for HBsAg, 402 of whom were also tested for anti-HCV The HBsAg positive subjects were tested for anti-HDV and 32 of them also for HbeAg/anti-Hbe. Separated commercial ELISA kits were used. HBsAg was detected in 132 (30.4%); 10.6% were co-infected with HDV Anti-HCV was detected in 15.4%. Five of 132 HbsAg positive patients (3.78%) were simultaneously HBV and HCV positive. Two patients out of 132 (1.52%) were positive to HBV, HCV and HDV Our data indicate that HBV infection was the main cause of chronic liver diseases in NorthEastern Bulgaria, and 10.6% of the patients suffered from severe disease because of co-infection with HDV HCV plays the same role in 15.4% of the cases. Recently, we observed dually infected (HBV and HCV) and triple infected (HBV, HCV, HDV) patients suffering from severe chronic liver diseases.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 28 条
[1]   Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia [J].
Abe, K ;
Hayakawa, E ;
Sminov, AV ;
Rossina, AL ;
Ding, X ;
Huy, TTT ;
Sata, T ;
Uchaikin, VF .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) :57-61
[2]  
Atanasova M V, 2004, Minerva Gastroenterol Dietol, V50, P89
[3]  
Chatterjee C., 2001, Indian J Med Microbiol, V19, P46
[4]   Viral replication in patients with concomitant hepatitis B and C virus infections [J].
Crespo, J ;
Lozano, JL ;
Carte, B ;
delasHeras, B ;
delaCruz, F ;
PonsRomero, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (06) :445-451
[5]   Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection [J].
Crockett S.D. ;
Keeffe E.B. .
Annals of Clinical Microbiology and Antimicrobials, 4 (1)
[6]   Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study [J].
Gaeta, GB ;
Stornaiuolo, G ;
Precone, DF ;
Lobello, S ;
Chiaramonte, M ;
Stroffolini, T ;
Colucci, G ;
Rizzetto, M .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1036-1041
[7]  
GAXI A, 1984, GUT, V25, P1288
[8]   RISKS OF CHRONICITY FOLLOWING ACUTE HEPATITIS-B VIRUS-INFECTION - A REVIEW [J].
HYAMS, KC .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :992-1000
[9]   Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference [J].
Jardi, R ;
Rodriguez, F ;
Buti, M ;
Costa, X ;
Cotrina, M ;
Galimany, R ;
Esteban, R ;
Guardia, J .
HEPATOLOGY, 2001, 34 (02) :404-410
[10]  
Kostev I, 2003, HEPATO-GASTROENTEROL, V50, P463